ART4 and hepatocellular carcinoma: have demonstrated that hepatocellular carcinoma-associated ECs can induce tumor-infiltrating T cell exhaustion through the expression of the glycoprotein nonmetastatic melanoma protein B (GPNMB), suggesting that GPNMB might be a novel therapeutic target in hepatocellular carcinoma (95) (Figure 1C).